225
Participants
Start Date
November 22, 2017
Primary Completion Date
December 17, 2020
Study Completion Date
December 17, 2020
Insulin degludec
Injection for subcutaneous (s.c., under the skin) use once daily. The total trial duration for subjects will be maximum 25 months
Insulin Aspart
Injection for subcutaneous (s.c., under the skin) use 2-4 times daily with meals. The total trial duration for subjects will be maximum 25 months
Insulin detemir
Injection for subcutaneous (s.c., under the skin) use, once daily or twice daily. The total trial duration for subjects will be maximum 25 months
Novo Nordisk Investigational Site, Vienna
Novo Nordisk Investigational Site, Vienna
Novo Nordisk Investigational Site, St Leonards
Novo Nordisk Investigational Site, København Ø
Novo Nordisk Investigational Site, Blacktown
Novo Nordisk Investigational Site, Campbelltown
Novo Nordisk Investigational Site, Parkville
Novo Nordisk Investigational Site, Box Hill
Novo Nordisk Investigational Site, Ipswich
Novo Nordisk Investigational Site, Salta
Novo Nordisk Investigational Site, Elizabeth Vale
Novo Nordisk Investigational Site, Mendoza
Novo Nordisk Investigational Site, Innsbruck
Novo Nordisk Investigational Site, Graz
Novo Nordisk Investigational Site, Aarhus N
Novo Nordisk Investigational Site, Torino
Novo Nordisk Investigational Site, Belgrade
Novo Nordisk Investigational Site, Athens
Novo Nordisk Investigational Site, Milan
Novo Nordisk Investigational Site, Milan
Novo Nordisk Investigational Site, Padua
Novo Nordisk Investigational Site, Petah Tikva
Novo Nordisk Investigational Site, Rehovot
Novo Nordisk Investigational Site, Moscow
Novo Nordisk Investigational Site, Saint Petersburg
Novo Nordisk Investigational Site, Saratov
Novo Nordisk Investigational Site, Yoshkar-Ola
Novo Nordisk Investigational Site, Ulyanovsk
Novo Nordisk Investigational Site, Kirov
Novo Nordisk Investigational Site, Yekaterinburg
Novo Nordisk Investigational Site, Tomsk
Novo Nordisk Investigational Site, CABA
Novo Nordisk Investigational Site, CABA
Novo Nordisk Investigational Site, CABA
Novo Nordisk Investigational Site, Córdoba
Novo Nordisk Investigational Site, Vienna
Novo Nordisk Investigational Site, Goiânia
Novo Nordisk Investigational Site, Curitiba
Novo Nordisk Investigational Site, Porto Alegre
Novo Nordisk Investigational Site, São Paulo
Novo Nordisk Investigational Site, São Paulo
Novo Nordisk Investigational Site, Ribeirão Preto
Novo Nordisk Investigational Site, Edmonton
Novo Nordisk Investigational Site, Vancouver
Novo Nordisk Investigational Site, St. John's
Novo Nordisk Investigational Site, Halifax
Novo Nordisk Investigational Site, Cambridge
Novo Nordisk Investigational Site, London
Novo Nordisk Investigational Site, Toronto
Novo Nordisk Investigational Site, Toronto
Novo Nordisk Investigational Site, PQ
Novo Nordisk Investigational Site, Zagreb
Novo Nordisk Investigational Site, Athens
Novo Nordisk Investigational Site, Larissa
Novo Nordisk Investigational Site, Nea Efkarpia - Thessaloniki
Novo Nordisk Investigational Site, Dublin
Novo Nordisk Investigational Site, Dublin
Novo Nordisk Investigational Site, Galway
Novo Nordisk Investigational Site, Roma
Novo Nordisk Investigational Site, Sant'Andrea Delle Fratte (PG)
Novo Nordisk Investigational Site, Barcelona
Novo Nordisk Investigational Site, Bath
Novo Nordisk Investigational Site, Bradford
Novo Nordisk Investigational Site, Cambridge
Novo Nordisk Investigational Site, High Wycombe
Novo Nordisk Investigational Site, Leeds
Novo Nordisk Investigational Site, Middlesbrough
Novo Nordisk Investigational Site, Norwich
Novo Nordisk Investigational Site, Nottingham
Novo Nordisk Investigational Site, Oxford
Novo Nordisk Investigational Site, Truro
Lead Sponsor
Novo Nordisk A/S
INDUSTRY